INSULIN GLARGINE-YFGN

INSULIN GLARGINE-YFGN was reported 22376 times

These side effects are most commonly reported by patients taking INSULIN GLARGINE-YFGN:

# Side effect Count
0 HYPOGLYCAEMIA 1741
1 BLOOD GLUCOSE INCREASED 1627
2 ACUTE KIDNEY INJURY 1066
3 DYSPNOEA 1005
4 NAUSEA 971
5 OFF LABEL USE 957
6 HYPERGLYCAEMIA 952
7 DRUG INEFFECTIVE 923
8 DIARRHOEA 919
9 VOMITING 856
10 FATIGUE 828
11 CONDITION AGGRAVATED 768
12 FALL 688
13 DIZZINESS 681
14 ASTHENIA 676
15 DRUG INTERACTION 644
16 PNEUMONIA 605
17 HYPOTENSION 595
18 MALAISE 581
19 PYREXIA 575
20 PAIN IN EXTREMITY 564
21 DIABETES MELLITUS INADEQUATE CONTROL 539
22 LACTIC ACIDOSIS 534
23 HEADACHE 521
24 ANAEMIA 506
25 PAIN 504
26 DIABETIC KETOACIDOSIS 501
27 WEIGHT DECREASED 493
28 DEHYDRATION 482
29 BLOOD GLUCOSE DECREASED 477
30 DECREASED APPETITE 468
31 GLYCOSYLATED HAEMOGLOBIN INCREASED 464
32 DEATH 457
33 ABDOMINAL PAIN 446
34 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 440
35 GENERAL PHYSICAL HEALTH DETERIORATION 437
36 HYPERTENSION 436
37 RENAL IMPAIRMENT 411
38 TOXICITY TO VARIOUS AGENTS 407
39 ANXIETY 402
40 RENAL FAILURE 401
41 CONFUSIONAL STATE 393
42 CEREBROVASCULAR ACCIDENT 391
43 ARTHRALGIA 383
44 URINARY TRACT INFECTION 370
45 MYOCARDIAL INFARCTION 366
46 VISUAL IMPAIRMENT 360
47 WEIGHT INCREASED 353
48 COUGH 338
49 HYPERKALAEMIA 338
50 SEPSIS 325
51 HYPERHIDROSIS 323
52 DEVICE MECHANICAL ISSUE 322
53 OEDEMA PERIPHERAL 321
54 LOSS OF CONSCIOUSNESS 318
55 CHEST PAIN 316
56 CONSTIPATION 306
57 PRURITUS 298
58 RASH 296
59 ABDOMINAL PAIN UPPER 287
60 BLOOD GLUCOSE FLUCTUATION 285
61 PERIPHERAL SWELLING 282
62 SOMNOLENCE 276
63 GAIT DISTURBANCE 273
64 COVID-19 267
65 RESPIRATORY FAILURE 264
66 BACK PAIN 254
67 ASTHMA 248
68 TREMOR 247
69 PRODUCT DOSE OMISSION 245
70 LUNG DISORDER 241
71 VASCULITIS 240
72 ATRIAL FIBRILLATION 238
73 MUSCULAR WEAKNESS 236
74 TACHYCARDIA 236
75 OVERDOSE 235
76 METABOLIC ACIDOSIS 234
77 BLOOD GLUCOSE ABNORMAL 232
78 HYPOTHYROIDISM 232
79 MEMORY IMPAIRMENT 232
80 SYNCOPE 231
81 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 226
82 HYPOXIA 224
83 HAEMOPTYSIS 223
84 HYPONATRAEMIA 220
85 WHEEZING 220
86 CATARACT 219
87 INTENTIONAL PRODUCT MISUSE 217
88 BLOOD CREATININE INCREASED 216
89 FEELING ABNORMAL 216
90 PULMONARY EMBOLISM 216
91 PRODUCT USE ISSUE 214
92 PULMONARY FIBROSIS 214
93 THROMBOCYTOPENIA 212
94 PRODUCT STORAGE ERROR 210
95 INSOMNIA 209
96 OBSTRUCTIVE AIRWAYS DISORDER 209
97 CARDIAC FAILURE 208
98 DIABETES MELLITUS 204
99 BLINDNESS 202
100 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 202
101 PULMONARY ALVEOLAR HAEMORRHAGE 202
102 CHRONIC KIDNEY DISEASE 201
103 BRADYCARDIA 199
104 HYPOKALAEMIA 197
105 NEUROLOGICAL SYMPTOM 197
106 INCORRECT DOSE ADMINISTERED 193
107 PULMONARY VASCULITIS 193
108 ABDOMINAL DISCOMFORT 192
109 BLOOD PRESSURE INCREASED 191
110 NEURITIS 190
111 SEIZURE 190
112 THROMBOSIS 190
113 HYPOAESTHESIA 188
114 DRUG INTOLERANCE 187
115 RESPIRATORY SYMPTOM 187
116 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 181
117 PALPITATIONS 180
118 ANAPHYLACTIC REACTION 179
119 INFECTION 179
120 RHABDOMYOLYSIS 179
121 CARDIAC DISORDER 177
122 PRODUCTIVE COUGH 177
123 MYALGIA 172
124 DEPRESSION 171
125 PRODUCT DOSE OMISSION ISSUE 171
126 VISION BLURRED 170
127 HOSPITALISATION 167
128 NEUROPATHY PERIPHERAL 167
129 DEVICE ISSUE 161
130 FULL BLOOD COUNT ABNORMAL 160
131 PLEURAL EFFUSION 160
132 TREATMENT NONCOMPLIANCE 160
133 HAEMOGLOBIN DECREASED 159
134 CARDIAC ARREST 158
135 ABDOMINAL DISTENSION 157
136 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 157
137 INJECTION SITE PAIN 157
138 INTENTIONAL OVERDOSE 157
139 NEUTROPENIA 157
140 ALANINE AMINOTRANSFERASE INCREASED 156
141 CARDIAC FAILURE CONGESTIVE 155
142 PRODUCT USE IN UNAPPROVED INDICATION 153
143 ARTERIOSCLEROSIS 149
144 GASTROINTESTINAL HAEMORRHAGE 148
145 DIABETIC METABOLIC DECOMPENSATION 147
146 GAIT INABILITY 147
147 ARTERIOSCLEROSIS CORONARY ARTERY 145
148 CELLULITIS 143
149 SEPTIC SHOCK 141
150 RENAL DISORDER 140
151 DYSPHAGIA 139
152 CHILLS 138
153 ACUTE MYOCARDIAL INFARCTION 137
154 HYPOGLYCAEMIC COMA 137
155 SUICIDE ATTEMPT 137
156 INTENTIONAL PRODUCT USE ISSUE 136
157 ASPARTATE AMINOTRANSFERASE INCREASED 135
158 MATERNAL EXPOSURE DURING PREGNANCY 132
159 HEART RATE INCREASED 130
160 NASOPHARYNGITIS 129
161 FEBRILE NEUTROPENIA 127
162 PLATELET COUNT DECREASED 127
163 MUSCLE SPASMS 125
164 PULMONARY OEDEMA 125
165 INFLUENZA 124
166 ARRHYTHMIA 123
167 NODULE 122
168 DEPRESSED LEVEL OF CONSCIOUSNESS 121
169 DRUG HYPERSENSITIVITY 120
170 FOETAL EXPOSURE DURING PREGNANCY 120
171 NORMOCHROMIC NORMOCYTIC ANAEMIA 119
172 PRODUCT QUALITY ISSUE 119
173 DRUG-INDUCED LIVER INJURY 117
174 FORCED EXPIRATORY VOLUME DECREASED 117
175 EUGLYCAEMIC DIABETIC KETOACIDOSIS 116
176 ACUTE RESPIRATORY FAILURE 115
177 MENTAL STATUS CHANGES 115
178 PANCREATITIS 115
179 SLEEP DISORDER 114
180 BALANCE DISORDER 113
181 HYPERSENSITIVITY 113
182 UNRESPONSIVE TO STIMULI 113
183 CONJUNCTIVITIS ALLERGIC 111
184 DEVICE DELIVERY SYSTEM ISSUE 111
185 DUST ALLERGY 110
186 MITE ALLERGY 110
187 MYCOTIC ALLERGY 110
188 PANCYTOPENIA 110
189 TOTAL LUNG CAPACITY ABNORMAL 110
190 ALOPECIA 109
191 HYPOACUSIS 109
192 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 108
193 COMA 108
194 COMPLETED SUICIDE 108
195 ERYTHEMA 107
196 SPIROMETRY ABNORMAL 106
197 LETHARGY 104
198 HAEMATOCHEZIA 103
199 KETOACIDOSIS 103
200 PARAESTHESIA 103
201 CARDIO-RESPIRATORY ARREST 102
202 MEDICATION ERROR 102
203 ANGIOEDEMA 101
204 BLOOD PRESSURE DECREASED 101
205 CORONARY ARTERY DISEASE 101
206 URTICARIA 101
207 AMNESIA 100
208 DRY SKIN 100
209 HAEMORRHAGE 100
210 NERVOUSNESS 100
211 UPPER RESPIRATORY TRACT INFECTION 100
212 MULTIPLE ORGAN DYSFUNCTION SYNDROME 99
213 COGNITIVE DISORDER 97
214 ENCEPHALOPATHY 97
215 OEDEMA 97
216 RENAL FAILURE ACUTE 97
217 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 96
218 SYSTEMIC INFECTION 96
219 DYSPEPSIA 95
220 ELECTROLYTE IMBALANCE 95
221 GASTROINTESTINAL DISORDER 95
222 SKIN EXFOLIATION 95
223 DIABETIC NEUROPATHY 94
224 HYPOPHAGIA 94
225 SHOCK 94
226 UNEVALUABLE EVENT 94
227 SWELLING 93
228 BRONCHITIS 92
229 HALLUCINATION 92
230 SKIN ULCER 92
231 STRESS 92
232 TRANSIENT ISCHAEMIC ATTACK 92
233 DISTURBANCE IN ATTENTION 91
234 LEUKOCYTOSIS 91
235 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 90
236 ANGINA PECTORIS 89
237 LOWER RESPIRATORY TRACT INFECTION 89
238 TACHYPNOEA 89
239 DISABILITY 87
240 AGITATION 86
241 CHEST DISCOMFORT 86
242 DYSURIA 85
243 GASTROOESOPHAGEAL REFLUX DISEASE 85
244 DIABETIC FOOT 84
245 HAEMATURIA 84
246 LOCALISED INFECTION 84
247 DEMENTIA 83
248 DIABETIC RETINOPATHY 83
249 DISORIENTATION 83
250 MOBILITY DECREASED 83
251 SEROTONIN SYNDROME 83
252 MUSCULOSKELETAL PAIN 82
253 CHOLELITHIASIS 81
254 DELIRIUM 81
255 ILLNESS 81
256 FLUID RETENTION 79
257 IMPAIRED GASTRIC EMPTYING 79
258 OXYGEN SATURATION DECREASED 79
259 DYSARTHRIA 78
260 MALIGNANT NEOPLASM PROGRESSION 78
261 ALTERED STATE OF CONSCIOUSNESS 77
262 BLOOD CHOLESTEROL INCREASED 77
263 DISCOMFORT 77
264 VENTRICULAR TACHYCARDIA 77
265 BLOOD CREATINE PHOSPHOKINASE INCREASED 76
266 EXPOSURE DURING PREGNANCY 76
267 HEPATIC CYTOLYSIS 76
268 PANCREATITIS ACUTE 76
269 CYTOKINE RELEASE SYNDROME 75
270 DIPLOPIA 75
271 DRUG ABUSE 75
272 INABILITY TO AFFORD MEDICATION 75
273 DRY MOUTH 74
274 MIGRAINE 74
275 PRODUCT PRESCRIBING ERROR 74
276 WHITE BLOOD CELL COUNT DECREASED 74
277 MOUTH HAEMORRHAGE 73
278 PHARYNGITIS 73
279 TOOTHACHE 73
280 BLOOD BILIRUBIN INCREASED 71
281 BLOOD TRIGLYCERIDES INCREASED 71
282 DEVICE DEFECTIVE 71
283 HEPATIC ENZYME INCREASED 71
284 ISCHAEMIC STROKE 71
285 SPEECH DISORDER 71
286 WOUND 71
287 ARTHRITIS 70
288 BLOOD UREA INCREASED 70
289 ASCITES 69
290 DRUG DOSE OMISSION 69
291 DRUG LEVEL INCREASED 69
292 DYSPNOEA EXERTIONAL 69
293 JOINT SWELLING 69
294 ROAD TRAFFIC ACCIDENT 69
295 CONTUSION 68
296 END STAGE RENAL DISEASE 68
297 HYPOVOLAEMIA 68
298 INTERSTITIAL LUNG DISEASE 68
299 NEOPLASM MALIGNANT 68
300 CEREBRAL INFARCTION 67
301 EYE DISORDER 67
302 INTERNATIONAL NORMALISED RATIO INCREASED 67
303 PRESYNCOPE 67
304 VERTIGO 67
305 LEUKOPENIA 66
306 LIMB DISCOMFORT 66
307 NEUTROPHIL COUNT DECREASED 66
308 PRODUCT ADMINISTRATION ERROR 66
309 WHITE BLOOD CELL COUNT INCREASED 66
310 EPISTAXIS 65
311 HAEMATEMESIS 65
312 TINNITUS 65
313 CAPILLARITIS 64
314 DISEASE PROGRESSION 64
315 HEPATIC STEATOSIS 64
316 NEPHROLITHIASIS 64
317 PANCREATIC CARCINOMA 64
318 BLOOD POTASSIUM INCREASED 63
319 COLITIS 63
320 GLOMERULAR FILTRATION RATE DECREASED 63
321 HYPOTHERMIA 63
322 RESTLESSNESS 63
323 HUMAN RHINOVIRUS TEST POSITIVE 62
324 JAUNDICE 62
325 MULTIPLE USE OF SINGLE-USE PRODUCT 62
326 OSTEOMYELITIS 62
327 RECTAL HAEMORRHAGE 62
328 C-REACTIVE PROTEIN INCREASED 61
329 HEPATIC FUNCTION ABNORMAL 61
330 PRODUCT MONITORING ERROR 61
331 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 61
332 UROSEPSIS 61
333 BLISTER 60
334 OROPHARYNGEAL PAIN 60
335 TUBULOINTERSTITIAL NEPHRITIS 60
336 URINARY INCONTINENCE 60
337 DIALYSIS 59
338 GLAUCOMA 59
339 MUSCLE TWITCHING 59
340 PNEUMONIA ASPIRATION 59
341 SKIN DISORDER 59
342 ACCIDENTAL OVERDOSE 58
343 DEEP VEIN THROMBOSIS 58
344 GASTRITIS 58
345 HEPATIC FAILURE 58
346 BLOOD ALKALINE PHOSPHATASE INCREASED 57
347 EYE PRURITUS 57
348 MYOCLONUS 57
349 PERICARDITIS 57
350 POLLAKIURIA 57
351 SUBARACHNOID HAEMORRHAGE 57
352 CONTRAINDICATED PRODUCT ADMINISTERED 56
353 ELECTROCARDIOGRAM ABNORMAL 56
354 HIP FRACTURE 56
355 OSTEOARTHRITIS 56
356 SKIN LESION 56
357 STAPHYLOCOCCAL INFECTION 56
358 URINARY RETENTION 56
359 EYE HAEMORRHAGE 55
360 INJECTION SITE BRUISING 55
361 LIP SWELLING 55
362 RESPIRATORY DISORDER 55
363 POLYURIA 54
364 EOSINOPHILIA 53
365 RENAL TUBULAR NECROSIS 53
366 CHOLESTASIS 52
367 GAMMA-GLUTAMYLTRANSFERASE INCREASED 52
368 LIVER DISORDER 52
369 PALLOR 52
370 SURGERY 52
371 DEVICE BREAKAGE 51
372 STOMATITIS 51
373 TONGUE BITING 51
374 ATRIAL TACHYCARDIA 50
375 COVID-19 PNEUMONIA 50
376 HAEMOLYTIC ANAEMIA 50
377 HEAD INJURY 50
378 MENTAL DISORDER 50
379 PAIN OF SKIN 50
380 PNEUMONIA HAEMOPHILUS 50
381 RESPIRATORY ARREST 50
382 AGRANULOCYTOSIS 49
383 EATING DISORDER 49
384 HAEMATOMA 49
385 HEART RATE DECREASED 49
386 HYPOMAGNESAEMIA 49
387 INFLAMMATION 49
388 LIMB INJURY 49
389 NECK PAIN 49
390 APHASIA 48
391 CEREBRAL HAEMORRHAGE 48
392 COLD SWEAT 48
393 DEPRESSED MOOD 48
394 DIABETIC COMA 48
395 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 48
396 FACIAL PAIN 48
397 FEELING HOT 48
398 INTENTIONAL DOSE OMISSION 48
399 ANOSMIA 47
400 BLINDNESS UNILATERAL 47
401 MELAENA 47
402 PRURITUS GENITAL 47
403 TYPE 2 DIABETES MELLITUS 47
404 BACTERAEMIA 46
405 BLOOD SODIUM DECREASED 46
406 CAROTID ARTERY OCCLUSION 46
407 CYANOSIS 46
408 ELECTROCARDIOGRAM QT PROLONGED 46
409 ORTHOSTATIC HYPOTENSION 46
410 RESPIRATORY DISTRESS 46
411 ABNORMAL BEHAVIOUR 45
412 ACIDOSIS 45
413 CHOLECYSTITIS 45
414 CYSTITIS 45
415 DEVICE MALFUNCTION 45
416 DRUG EXPOSURE DURING PREGNANCY 45
417 TENSION HEADACHE 45
418 THIRST 45
419 UPPER GASTROINTESTINAL HAEMORRHAGE 45
420 VIRAL TEST POSITIVE 45
421 BLINDNESS TRANSIENT 44
422 CARDIOGENIC SHOCK 44
423 CARDIOSPASM 44
424 CARDIOTOXICITY 44
425 DIABETIC NEPHROPATHY 44
426 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 44
427 HEPATIC CIRRHOSIS 44
428 INJECTION SITE HAEMORRHAGE 44
429 KLEBSIELLA INFECTION 44
430 RASH MACULO-PAPULAR 44
431 SLEEP TERROR 44
432 SUICIDAL IDEATION 44
433 WRONG PRODUCT ADMINISTERED 44
434 BURNING SENSATION 43
435 FLATULENCE 43
436 FLUID OVERLOAD 43
437 FLUSHING 43
438 PALMOPLANTAR KERATODERMA 43
439 PERICARDIAL EFFUSION 43
440 PNEUMONITIS 43
441 PRODUCT DISPENSING ERROR 43
442 RHINORRHOEA 43
443 SINUS BRADYCARDIA 43
444 TRANSAMINASES INCREASED 43
445 UNDERDOSE 43
446 ACUTE RESPIRATORY DISTRESS SYNDROME 42
447 BREAST CANCER 42
448 CLOSTRIDIUM DIFFICILE COLITIS 42
449 GANGRENE 42
450 GASTROENTERITIS 42
451 GENERALISED OEDEMA 42
452 HAEMATOCRIT DECREASED 42
453 HERPES ZOSTER 42
454 INFUSION RELATED REACTION 42
455 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 42
456 PEMPHIGOID 42
457 PYELONEPHRITIS 42
458 BLOOD POTASSIUM DECREASED 41
459 BLOOD PRESSURE SYSTOLIC INCREASED 41
460 CARDIOVASCULAR DISORDER 41
461 DYSPHONIA 41
462 FAECES DISCOLOURED 41
463 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 41
464 RASH PRURITIC 41
465 TREATMENT FAILURE 41
466 EYE PAIN 40
467 HYPOCALCAEMIA 40
468 INJECTION SITE MASS 40
469 INSULIN RESISTANCE 40
470 INTESTINAL OBSTRUCTION 40
471 MYOPATHY 40
472 SINUSITIS 40
473 ADVERSE EVENT 39
474 DRUG ERUPTION 39
475 HYPERTENSIVE CRISIS 39
476 PSORIASIS 39
477 RED BLOOD CELL COUNT DECREASED 39
478 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 39
479 ADRENAL INSUFFICIENCY 38
480 ADVERSE DRUG REACTION 38
481 BONE PAIN 38
482 DEAFNESS 38
483 EJECTION FRACTION DECREASED 38
484 HEART RATE IRREGULAR 38
485 HEPATITIS 38
486 HYPERTHYROIDISM 38
487 MOVEMENT DISORDER 38
488 NEURALGIA 38
489 PAIN IN JAW 38
490 PROTEINURIA 38
491 PULMONARY HYPERTENSION 38
492 SWELLING FACE 38
493 ANURIA 37
494 CLOSTRIDIUM DIFFICILE INFECTION 37
495 CYTOMEGALOVIRUS INFECTION 37
496 DIVERTICULITIS 37
497 EXPIRED PRODUCT ADMINISTERED 37
498 ILL-DEFINED DISORDER 37
499 IMPAIRED HEALING 37
500 LYMPHOCYTE COUNT DECREASED 37
501 MUSCULOSKELETAL STIFFNESS 37
502 NEPHROPATHY 37
503 NEUROLEPTIC MALIGNANT SYNDROME 37
504 RHEUMATOID ARTHRITIS 37
505 TOE AMPUTATION 37
506 DISEASE RECURRENCE 36
507 DYSGEUSIA 36
508 FRACTURE 36
509 GENERALISED TONIC-CLONIC SEIZURE 36
510 HAEMOGLOBIN INCREASED 36
511 HEMIPARESIS 36
512 LIVER FUNCTION TEST INCREASED 36
513 RETINOPATHY 36
514 SKIN DISCOLOURATION 36
515 THERAPY NON-RESPONDER 36
516 VISUAL ACUITY REDUCED 36
517 CLOSTRIDIUM TEST POSITIVE 35
518 FUNGAL INFECTION 35
519 HYPOGLYCAEMIC UNCONSCIOUSNESS 35
520 LIVER FUNCTION TEST ABNORMAL 35
521 PULSELESS ELECTRICAL ACTIVITY 35
522 RESPIRATORY TRACT INFECTION 35
523 RETINAL DETACHMENT 35
524 SCIATICA 35
525 SOPOR 35
526 ABORTION SPONTANEOUS 34
527 BLOOD LACTATE DEHYDROGENASE INCREASED 34
528 HEPATOTOXICITY 34
529 INJECTION SITE PRURITUS 34
530 IRRITABILITY 34
531 THERAPY CESSATION 34
532 BLOOD PRESSURE ABNORMAL 33
533 DECUBITUS ULCER 33
534 HOT FLUSH 33
535 HYPERLIPIDAEMIA 33
536 HYPERTRIGLYCERIDAEMIA 33
537 RASH ERYTHEMATOUS 33
538 RENAL FAILURE CHRONIC 33
539 SUPRAVENTRICULAR TACHYCARDIA 33
540 SWOLLEN TONGUE 33
541 TOXIC EPIDERMAL NECROLYSIS 33
542 VIRAL INFECTION 33
543 ABSCESS 32
544 BACTERIAL INFECTION 32
545 DYSSTASIA 32
546 EPILEPSY 32
547 FEELING COLD 32
548 GOUT 32
549 INFLUENZA LIKE ILLNESS 32
550 INJECTION SITE ERYTHEMA 32
551 INTERVERTEBRAL DISC PROTRUSION 32
552 MALNUTRITION 32
553 MAST CELL ACTIVATION SYNDROME 32
554 NEUROTOXICITY 32
555 PREMATURE BABY 32
556 RIB FRACTURE 32
557 SALIVARY HYPERSECRETION 32
558 SARS-COV-2 TEST POSITIVE 32
559 SMALL INTESTINAL OBSTRUCTION 32
560 ASPHYXIA 31
561 CARDIAC OPERATION 31
562 ERECTILE DYSFUNCTION 31
563 HEPATIC ENCEPHALOPATHY 31
564 INJURY ASSOCIATED WITH DEVICE 31
565 LYMPHADENOPATHY 31
566 NEUTROPHIL COUNT INCREASED 31
567 SLEEP APNOEA SYNDROME 31
568 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 31
569 THERAPY INTERRUPTED 31
570 ATRIOVENTRICULAR BLOCK 30
571 BODY TEMPERATURE INCREASED 30
572 CANDIDA INFECTION 30
573 HYPERVOLAEMIA 30
574 HYPOGLYCAEMIC ENCEPHALOPATHY 30
575 INJURY 30
576 MUSCLE ATROPHY 30
577 NEEDLE ISSUE 30
578 OBESITY 30
579 PANCREATIC DISORDER 30
580 RASH PAPULAR 30
581 RENAL INJURY 30
582 SHOCK HAEMORRHAGIC 30
583 THERAPEUTIC RESPONSE DECREASED 30
584 TYPE 1 DIABETES MELLITUS 30
585 ANAL INCONTINENCE 29
586 BEDRIDDEN 29
587 CARDIAC FAILURE ACUTE 29
588 CHROMATURIA 29
589 CIRCULATORY COLLAPSE 29
590 DEVICE LEAKAGE 29
591 EMOTIONAL DISTRESS 29
592 ENTEROCOCCAL INFECTION 29
593 FEMUR FRACTURE 29
594 HUNGER 29
595 HYPOVOLAEMIC SHOCK 29
596 IMMUNISATION 29
597 INCREASED APPETITE 29
598 LIVER INJURY 29
599 NEPHROPATHY TOXIC 29
600 NO ADVERSE EVENT 29
601 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 29
602 PULMONARY CONGESTION 29
603 STENT PLACEMENT 29
604 AGGRESSION 28
605 BRAIN INJURY 28
606 DEVICE OPERATIONAL ISSUE 28
607 EYE MOVEMENT DISORDER 28
608 KIDNEY INFECTION 28
609 LOWER GASTROINTESTINAL HAEMORRHAGE 28
610 OLIGURIA 28
611 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 28
612 PARALYSIS 28
613 PHARYNGEAL SWELLING 28
614 POLYDIPSIA 28
615 ABSCESS LIMB 27
616 ATELECTASIS 27
617 ATRIAL FLUTTER 27
618 DYSKINESIA 27
619 DYSLIPIDAEMIA 27
620 FOURNIER^S GANGRENE 27
621 HAEMATOCRIT INCREASED 27
622 HAEMODIALYSIS 27
623 HAEMORRHAGIC STROKE 27
624 HEMIPLEGIA 27
625 HYPOKINESIA 27
626 INCORRECT DOSE ADMINISTERED BY DEVICE 27
627 KETOSIS 27
628 LOWER LIMB FRACTURE 27
629 MUCOSAL INFLAMMATION 27
630 NIGHT SWEATS 27
631 PLASMA CELL MYELOMA 27
632 POST PROCEDURAL COMPLICATION 27
633 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 27
634 RASH MACULAR 27
635 SEDATION 27
636 THERAPY PARTIAL RESPONDER 27
637 UPPER LIMB FRACTURE 27
638 DEVICE RELATED INFECTION 26
639 ECZEMA 26
640 ENTEROCOLITIS 26
641 EXTRA DOSE ADMINISTERED 26
642 GASTRIC ULCER 26
643 HYPOTONIA 26
644 LEFT ATRIAL DILATATION 26
645 MUCOSAL DRYNESS 26
646 MYOSITIS 26
647 NASAL CONGESTION 26
648 PNEUMONIA BACTERIAL 26
649 PRODUCT PRESCRIBING ISSUE 26
650 PULMONARY MASS 26
651 SINUS TACHYCARDIA 26
652 THYROID DISORDER 26
653 TOXIC SKIN ERUPTION 26
654 ACCIDENTAL EXPOSURE TO PRODUCT 25
655 ARTERIAL OCCLUSIVE DISEASE 25
656 ARTHROPATHY 25
657 ASPERGILLUS INFECTION 25
658 ASPIRATION 25
659 COGWHEEL RIGIDITY 25
660 DRUG RESISTANCE 25
661 DYSTONIA 25
662 ESCHERICHIA URINARY TRACT INFECTION 25
663 EYE SWELLING 25
664 HAEMORRHOIDS 25
665 HYDRONEPHROSIS 25
666 HYPERCHOLESTEROLAEMIA 25
667 ILEUS 25
668 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25
669 NEUTROPHILIA 25
670 OSTEOPOROSIS 25
671 PARKINSON^S DISEASE 25
672 PREMATURE DELIVERY 25
673 PRODUCT STORAGE ISSUE 25
674 RENAL TRANSPLANT 25
675 THROAT TIGHTNESS 25
676 BLOOD CALCIUM INCREASED 24
677 CONJOINED TWINS 24
678 CORONARY ARTERY OCCLUSION 24
679 DRY EYE 24
680 ERYTHEMA MULTIFORME 24
681 HYPERSOMNIA 24
682 HYPOPHOSPHATAEMIA 24
683 IRON DEFICIENCY ANAEMIA 24
684 JOINT INJURY 24
685 LEG AMPUTATION 24
686 LUNG NEOPLASM MALIGNANT 24
687 LYMPHOPENIA 24
688 NEPHROGENIC ANAEMIA 24
689 PERIODONTITIS 24
690 PERITONITIS 24
691 POOR QUALITY SLEEP 24
692 PULMONARY ARTERIAL HYPERTENSION 24
693 APHONIA 23
694 BLADDER CANCER 23
695 CHOLANGITIS 23
696 CONVULSION 23
697 DIABETIC COMPLICATION 23
698 FACIAL PARALYSIS 23
699 FEAR 23
700 HEPATOMEGALY 23
701 INJECTION SITE SWELLING 23
702 MUSCULOSKELETAL CHEST PAIN 23
703 NEOPLASM PROGRESSION 23
704 NEUROLOGICAL DECOMPENSATION 23
705 PRODUCT DOSE OMISSION IN ERROR 23
706 RETCHING 23
707 STATUS EPILEPTICUS 23
708 VITAMIN B12 DEFICIENCY 23
709 VITAMIN D DEFICIENCY 23
710 BLOOD IRON DECREASED 22
711 BONE DISORDER 22
712 BRONCHOPULMONARY ASPERGILLOSIS 22
713 CATARACT OPERATION 22
714 CHOLECYSTITIS ACUTE 22
715 CRYPTOCOCCOSIS 22
716 DEMENTIA ALZHEIMER^S TYPE 22
717 FEEDING DISORDER 22
718 HALLUCINATION, AUDITORY 22
719 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 22
720 HYPERLACTACIDAEMIA 22
721 INSULIN AUTOIMMUNE SYNDROME 22
722 LOW DENSITY LIPOPROTEIN INCREASED 22
723 MACULAR DEGENERATION 22
724 MENTAL IMPAIRMENT 22
725 MOUTH ULCERATION 22
726 NERVOUS SYSTEM DISORDER 22
727 OESOPHAGITIS 22
728 POST PROCEDURAL INFECTION 22
729 PROSTATE CANCER 22
730 PSEUDOMONAS INFECTION 22
731 RASH GENERALISED 22
732 RIGHT VENTRICULAR FAILURE 22
733 THERAPEUTIC DRUG MONITORING ANALYSIS INCORRECTLY PERFORMED 22
734 TOXIC ENCEPHALOPATHY 22
735 URINE OUTPUT DECREASED 22
736 WITHDRAWAL SYNDROME 22
737 ACUTE HEPATIC FAILURE 21
738 BONE MARROW FAILURE 21
739 CHOKING 21
740 COAGULOPATHY 21
741 DRUG WITHDRAWAL SYNDROME 21
742 HAEMODYNAMIC INSTABILITY 21
743 HYPERBILIRUBINAEMIA 21
744 HYPERSENSITIVITY VASCULITIS 21
745 INJECTION SITE INDURATION 21
746 KETONURIA 21
747 LEFT VENTRICULAR DYSFUNCTION 21
748 LEFT VENTRICULAR HYPERTROPHY 21
749 LYMPHOMA 21
750 METABOLIC DISORDER 21
751 PNEUMONIA STAPHYLOCOCCAL 21
752 POTENTIATING DRUG INTERACTION 21
753 PRODUCT SUBSTITUTION ISSUE 21
754 PSYCHIATRIC SYMPTOM 21
755 PSYCHOTIC DISORDER 21
756 RALES 21
757 RED CELL DISTRIBUTION WIDTH INCREASED 21
758 ULCER 21
759 VENTRICULAR FIBRILLATION 21
760 WOUND INFECTION 21
761 AGEUSIA 20
762 AMYLOIDOSIS 20
763 ATRIOVENTRICULAR BLOCK COMPLETE 20
764 BACK DISORDER 20
765 BLOOD ALBUMIN DECREASED 20
766 CARDIOPULMONARY FAILURE 20
767 CRYSTAL NEPHROPATHY 20
768 DEVICE USE ISSUE 20
769 DRUG CLEARANCE DECREASED 20
770 DUODENAL ULCER 20
771 ERUCTATION 20
772 FOOT FRACTURE 20
773 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 20
774 HIATUS HERNIA 20
775 HYPERCALCAEMIA 20
776 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 20
777 KNEE ARTHROPLASTY 20
778 METABOLIC ENCEPHALOPATHY 20
779 NON-CARDIOGENIC PULMONARY OEDEMA 20
780 POISONING DELIBERATE 20
781 RENAL PAIN 20
782 SPLENOMEGALY 20
783 SUBDURAL HAEMATOMA 20
784 TOOTH DISORDER 20
785 TRANSPLANT REJECTION 20
786 ANGINA UNSTABLE 19
787 ANKLE FRACTURE 19
788 ANTI-INSULIN ANTIBODY POSITIVE 19
789 BLOOD LACTIC ACID INCREASED 19
790 BLOOD THYROID STIMULATING HORMONE INCREASED 19
791 DERMATITIS EXFOLIATIVE GENERALISED 19
792 DEVICE FAILURE 19
793 DIABETIC FOOT INFECTION 19
794 FOOT AMPUTATION 19
795 FREQUENT BOWEL MOVEMENTS 19
796 GASTROINTESTINAL HYPOMOTILITY 19
797 HAEMATOMA MUSCLE 19
798 METASTASES TO LIVER 19
799 NOCTURIA 19
800 PERITONITIS BACTERIAL 19
801 PROCEDURAL PAIN 19
802 RESPIRATORY RATE INCREASED 19
803 RETINAL HAEMORRHAGE 19
804 STEVENS-JOHNSON SYNDROME 19
805 SUDDEN DEATH 19
806 SUSPECTED SUICIDE 19
807 VAGINAL HAEMORRHAGE 19
808 ATRIOVENTRICULAR BLOCK SECOND DEGREE 18
809 BLOOD CALCIUM DECREASED 18
810 BLOOD URIC ACID INCREASED 18
811 CACHEXIA 18
812 CARDIOMEGALY 18
813 DERMATITIS BULLOUS 18
814 DERMATITIS EXFOLIATIVE 18
815 GASTRIC DISORDER 18
816 GLYCOSURIA 18
817 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 18
818 INJECTION SITE DISCOLOURATION 18
819 INJECTION SITE RASH 18
820 INTERNATIONAL NORMALISED RATIO FLUCTUATION 18
821 INTESTINAL ISCHAEMIA 18
822 LUNG INFECTION 18
823 MITRAL VALVE INCOMPETENCE 18
824 NECROTISING FASCIITIS 18
825 OLIGOHYDRAMNIOS 18
826 PERIPHERAL ISCHAEMIA 18
827 PNEUMOCYSTIS JIROVECII PNEUMONIA 18
828 PRODUCT DISPENSING ISSUE 18
829 ROTATOR CUFF SYNDROME 18
830 SENSORY DISTURBANCE 18
831 SKIN HAEMORRHAGE 18
832 SUBCUTANEOUS ABSCESS 18
833 TASTE DISORDER 18
834 THERAPEUTIC RESPONSE UNEXPECTED 18
835 VENTRICULAR EXTRASYSTOLES 18
836 ABDOMINAL PAIN LOWER 17
837 BLOOD CREATININE ABNORMAL 17
838 BLOOD PRESSURE FLUCTUATION 17
839 BRAIN NEOPLASM 17
840 CARDIAC FAILURE CHRONIC 17
841 CHOLECYSTECTOMY 17
842 CONJUNCTIVITIS 17
843 DISSEMINATED INTRAVASCULAR COAGULATION 17
844 FACE OEDEMA 17
845 FLANK PAIN 17
846 GASTROENTERITIS VIRAL 17
847 HYPOGAMMAGLOBULINAEMIA 17
848 INJECTION SITE HYPERTROPHY 17
849 JOINT DISLOCATION 17
850 LACRIMATION INCREASED 17
851 MUSCLE RIGIDITY 17
852 MYELOSUPPRESSION 17
853 MYOCARDIAL ISCHAEMIA 17
854 PANCREATIC CARCINOMA METASTATIC 17
855 PELVIC FRACTURE 17
856 PROTHROMBIN TIME PROLONGED 17
857 PRURITUS GENERALISED 17
858 RESPIRATORY DEPRESSION 17
859 SERUM FERRITIN INCREASED 17
860 TENDONITIS 17
861 TONGUE INJURY 17
862 WEIGHT FLUCTUATION 17
863 WOUND COMPLICATION 17
864 AMENORRHOEA 16
865 ANAPHYLACTIC SHOCK 16
866 BLOOD CHLORIDE DECREASED 16
867 BLOOD CREATINE INCREASED 16
868 BLOOD DISORDER 16
869 BREAST PAIN 16
870 BUNDLE BRANCH BLOCK LEFT 16
871 CRYING 16
872 DIZZINESS POSTURAL 16
873 DRUG DISPENSING ERROR 16
874 GINGIVAL HYPERTROPHY 16
875 HERNIA 16
876 HYPERURICAEMIA 16
877 HYPOALBUMINAEMIA 16
878 INJECTION SITE REACTION 16
879 INTERNAL HAEMORRHAGE 16
880 JOINT EFFUSION 16
881 JOINT STIFFNESS 16
882 MOOD ALTERED 16
883 NEPHROTIC SYNDROME 16
884 OCULAR HYPERAEMIA 16
885 ORAL PAIN 16
886 PERIPHERAL COLDNESS 16
887 PETECHIAE 16
888 POLYNEUROPATHY 16
889 PRESCRIBED UNDERDOSE 16
890 RESPIRATORY ACIDOSIS 16
891 SCAR 16
892 SKIN BURNING SENSATION 16
893 SLUGGISHNESS 16
894 SPINAL DISORDER 16
895 STENOSIS 16
896 THROMBOCYTOSIS 16
897 URINE KETONE BODY PRESENT 16
898 BLOOD URINE PRESENT 15
899 CARDIOMYOPATHY 15
900 CARPAL TUNNEL SYNDROME 15
901 CEREBRAL DISORDER 15
902 CONGESTIVE CARDIOMYOPATHY 15
903 CREATININE RENAL CLEARANCE DECREASED 15
904 CREPITATIONS 15
905 DELUSION 15
906 DIABETIC KETOSIS 15
907 DISORGANISED SPEECH 15
908 DIVERTICULUM INTESTINAL 15
909 EAR INFECTION 15
910 EMPHYSEMA 15
911 ESCHERICHIA SEPSIS 15
912 GALLBLADDER DISORDER 15
913 GASTRIC HAEMORRHAGE 15
914 GASTRITIS EROSIVE 15
915 GINGIVAL BLEEDING 15
916 GLOMERULAR FILTRATION RATE INCREASED 15
917 HAEMORRHAGE INTRACRANIAL 15
918 HEPATIC NEOPLASM 15
919 HYPERKERATOSIS 15
920 HYPERNATRAEMIA 15
921 HYPOGLYCAEMIA UNAWARENESS 15
922 IMMUNE-MEDIATED MYOSITIS 15
923 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 15
924 IMPAIRED WORK ABILITY 15
925 INFARCTION 15
926 INFUSION SITE ERYTHEMA 15
927 INTESTINAL PERFORATION 15
928 MACULAR OEDEMA 15
929 MUSCULOSKELETAL DISCOMFORT 15
930 OCULOGYRIC CRISIS 15
931 OSTEOPENIA 15
932 PNEUMONIA FUNGAL 15
933 PNEUMOTHORAX 15
934 PYELOCALIECTASIS 15
935 RESTLESS LEGS SYNDROME 15
936 SKIN IRRITATION 15
937 SPINAL STENOSIS 15
938 STEROID DIABETES 15
939 SUPRAVENTRICULAR EXTRASYSTOLES 15
940 THROAT IRRITATION 15
941 TROPONIN INCREASED 15
942 URETERIC COMPRESSION 15
943 VARICOSE VEIN 15
944 VASCULAR GRAFT 15
945 ACCIDENT 14
946 AMYLASE INCREASED 14
947 ANGER 14
948 ANHEDONIA 14
949 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 14
950 ATRIAL SEPTAL DEFECT 14
951 AUTONOMIC NEUROPATHY 14
952 BREATH SOUNDS ABNORMAL 14
953 CHOREA 14
954 COLON CANCER 14
955 CUTANEOUS VASCULITIS 14
956 DRUG EFFECT LESS THAN EXPECTED 14
957 EMBOLISM 14
958 FIBROMYALGIA 14
959 FOETAL DEATH 14
960 ILEUS PARALYTIC 14
961 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 14
962 LACUNAR INFARCTION 14
963 LIPASE INCREASED 14
964 LIPOHYPERTROPHY 14
965 LOW BIRTH WEIGHT BABY 14
966 LUNG CONSOLIDATION 14
967 METHAEMOGLOBINAEMIA 14
968 MONOPLEGIA 14
969 MULTI-ORGAN FAILURE 14
970 MYELODYSPLASTIC SYNDROME 14
971 NECROSIS 14
972 NEOPLASM 14
973 OSTEONECROSIS OF JAW 14
974 PLATELET COUNT INCREASED 14
975 POISONING 14
976 PSEUDOMEMBRANOUS COLITIS 14
977 PSYCHOMOTOR SKILLS IMPAIRED 14
978 PULSE ABSENT 14
979 REBOUND EFFECT 14
980 REFUSAL OF TREATMENT BY PATIENT 14
981 SCRATCH 14
982 SENSORY LOSS 14
983 SPINAL PAIN 14
984 STAPHYLOCOCCAL SEPSIS 14
985 TRICHOGLOSSIA 14
986 TUBERCULOSIS 14
987 URINARY TRACT DISORDER 14
988 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13
989 ANGIOPATHY 13
990 BASAL CELL CARCINOMA 13
991 CEREBRAL ISCHAEMIA 13
992 CROHN^S DISEASE 13
993 CUSHING^S SYNDROME 13
994 DRUG EFFECT DECREASED 13
995 ECCHYMOSIS 13
996 ESSENTIAL HYPERTENSION 13
997 EXTREMITY NECROSIS 13
998 EYE OEDEMA 13
999 GASTROINTESTINAL INFECTION 13